Dimensional Fund Advisors
ONC

Dimensional Fund Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Dimensional Fund Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Sell
46,733
-10,146
-18% -$2.99M ﹤0.01% 2194
2026
Q1 		$16.9M Buy
56,879
+7,815
+16% +$2.53M ﹤0.01% 2049
2025
Q4 		$14.9M Buy
49,064
+9,272
+23% +$3.03M ﹤0.01% 2121
2025
Q3 		$13.5M Buy
39,792
+9,277
+30% +$2.82M ﹤0.01% 2181
2025
Q2 		$7.39M Buy
30,515
+8,521
+39% +$2.09M ﹤0.01% 2397
2025
Q1 		$5.97M Buy
21,994
+538
+3% +$126K ﹤0.01% 2449
2024
Q4 		$3.96M Buy
21,456
+441
+2% +$90.1K ﹤0.01% 2601
2024
Q3 		$4.7M Buy
21,015
+9,516
+83% +$1.71M ﹤0.01% 2530
2024
Q2 		$1.65M Buy
11,499
+6,246
+119% +$963K ﹤0.01% 2805
2024
Q1 		$822K Sell
5,253
-6,036
-53% -$972K ﹤0.01% 2953
2023
Q4 		$2.04M Sell
11,289
-195
-2% -$35.3K ﹤0.01% 2788
2023
Q3 		$2.07M Sell
11,484
-710
-6% -$140K ﹤0.01% 2773
2023
Q2 		$2.18M Sell
12,194
-275
-2% -$63.3K ﹤0.01% 2758
2023
Q1 		$2.69M Buy
+12,469
New +$2.99M ﹤0.01% 2663
2022
Q3 		$1.93M Sell
14,315
-928
-6% -$159K ﹤0.01% 2719
2022
Q2 		$2.46M Sell
15,243
-125
-0.8% -$19.5K ﹤0.01% 2683
2022
Q1 		$2.94M Buy
15,368
+2,047
+15% +$435K ﹤0.01% 2712
2021
Q4 		$3.61M Sell
13,321
-202
-1% -$68.2K ﹤0.01% 2670
2021
Q3 		$4.91M Sell
13,523
-6,919
-34% -$2.26M ﹤0.01% 2592
2021
Q2 		$7.05M Sell
20,442
-3,207
-14% -$1.06M ﹤0.01% 2493
2021
Q1 		$8.15M Buy
23,649
+412
+2% +$136K ﹤0.01% 2411
2020
Q4 		$5.99M Buy
23,237
+57
+0.2% +$15.7K ﹤0.01% 2461
2020
Q3 		$6.62M Buy
23,180
+807
+4% +$190K ﹤0.01% 2368
2020
Q2 		$4.22M Buy
22,373
+7,347
+49% +$1.2M ﹤0.01% 2533
2020
Q1 		$1.85M Buy
15,026
+12,577
+514% +$1.97M ﹤0.01% 2733
2019
Q4 		$406K Sell
2,449
-128
-5% -$21.3K ﹤0.01% 3164
2019
Q3 		$316K Buy
+2,577
New +$342K ﹤0.01% 3213

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors's ONC Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its BeOne Medicines Ltd (ONC) stake by 18% in Q2 2026, selling an estimated $2.99M and leaving 46,733 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Dimensional Fund Advisors first reported a position in ONC in Q3 2019 and has held it in 27 quarters since. The position peaked at $16.9M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Dimensional Fund Advisors held 46,733 shares of BeOne Medicines Ltd worth $13.3M as of Q2 2026.
  • Dimensional Fund Advisors sold 10,146 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.99M.
  • BeOne Medicines Ltd made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2194 holding.
  • Dimensional Fund Advisors first reported a position in BeOne Medicines Ltd in Q3 2019 and has held it in 27 quarters since.
  • Dimensional Fund Advisors's BeOne Medicines Ltd position peaked at $16.9M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.